The round was led by King River Capital, as well as a $15 million venture debt credit facility with Trinity Capital and Bridge Bank. The round also includes new investors Franklin Templeton, SteelSky Ventures, and Olive Tree Capital; and existing Lark investors Lightspeed Ventures, Asset Management Ventures, Dr. Jonathan Fielding of UCLA Fielding School of Public Health, and Weili Dai, cofounder of Marvell. Lark has raised a total of over $100 million in equity and debt funding to date.

Lark Health is a chronic disease prevention and management company that uses a cognitive behavioral therapy framework, conversational A.I., and connected devices to help people stay healthy and in control of their conditions. Lark's A.I. is continuously learning how to personalize the experience for the member and communicates via text-message-like interactions to monitor patients remotely, 24/7, while live nurses and health coaches are available when issues need to be escalated such as severe readings or medication changes. Lark's Diabetes Prevention Program (DPP), which is Fully-Recognized by the Centers for Disease Control and Prevention, Behavioral Health Program, Diabetes Care Program, and Hypertension Program have served nearly 2 million members, and have demonstrated clinically validated outcomes. Lark works with many of the largest health plans and self-insured employers to help their members and employees live healthier lives. Founded by CEO Julia Hu and CTO Jeff Zira in 2011, the company has received numerous awards, including being named by Fierce Healthcare as one of 2020's Fierce 15 most promising companies in healthcare. To learn more, visit www.lark.com.